Ro

Zepbound KwikPen now on Ro: a simpler way to take the most effective GLP-1. Four weekly shots in a single pen—no vials or syringes required. https://lnkd.in/grxnHrnk ✔️ Same cash price as Zepbound vials ✔️ Prescribed online, if eligible ✔️ Delivered directly to patients We’ll keep expanding access to the latest innovations to make getting high-quality care easier for patients.

Introducing new Wegovy savings on Ro—helping patients save up to $1,200/year. https://lnkd.in/ekHrJADN By working with Novo Nordisk, Ro is offering the lowest available cash prices for Wegovy,  putting effective, FDA-approved GLP-1s within reach for more patients. Ro continues to fight for patients by offering these lower GLP-1 prices alongside new ways to save on our Body membership (launching soon), so patients can get the treatment and high-quality care they need to achieve their goals. Find out more below.

GLP-1s are transforming healthcare—but we’re still in the early innings. In the latest episode of Rapid Response, Ro CEO Zachariah Reitano shares why the next phase of this evolution will be defined by how we scale access, reduce stigma, and deliver real outcomes for patients. Listen to the full episode here: https://lnkd.in/dgErk_e6

Ro was recognized in the Forbes 2026 America’s Best Startups Employers list! https://lnkd.in/dGSX3ahr Thank you to every Ro’er for making it happen, and bringing your best every day as you fight for patients. 

When Hannah started GLP-1 treatment on Ro, she never imagined she could be a runner. Just a year and a half later, she crossed the finish line of her first marathon. Our team flew to Minnesota to capture this incredible milestone in a short documentary. https://lnkd.in/e_zEsee5 As her health improved on Ro, Hannah started dreaming bigger. Reaching her health goals unlocked new life goals. That’s when her running journey began. Her story is a reminder that when obesity care starts with a patient’s goals, the impact goes beyond the number on a scale—it can help support them in pursuing healthier, fuller lives.

I spoke with BuzzFeed Business about how Ro's Super Bowl debut with Serena Williams is helping reframe weight loss medications—shifting the conversation toward real outcomes, real patients, and long-term health. “As an athlete, Serena is one of one. But as someone struggling with weight loss, she’s one of millions.” Read the full story: https://lnkd.in/ejKV58iM

“GLP-1s are forcing an incredible rewiring of the health care system." Ro CEO Zachariah Reitano spoke with Fortune’s Diane Brady about how these innovative medicines go beyond weight loss—improving patients’ underlying health and long-term outcomes. Removing the stigma around these treatments is key to expanding access and helping more patients live longer, more fulfilled lives. Read more here: https://lnkd.in/eMPXaCrT

Ro co-founder and Chief Product Officer, Saman Rahmanian, shared how our Super Bowl ad is, “tackling the misconception that weight loss medications are only for vanity...We know that the value of GLP-1s is more than skin deep.” Read the rest of Saman's conversation with ADWEEK to learn more about our 'Healthier on Ro' campaign: https://lnkd.in/e5PUftDX

Want a behind the scenes look at the making of our Super Bowl ad? Ro’s Chief Product Officer and co-founder Saman Rahmanian dives into all the ideation, teamwork, and creative processes involved in this blog:  https://lnkd.in/etSe59uA

Want an under the hood understanding of Super Bowl advertising? Ro’s CEO & co-founder Zachariah Reitano explains why companies choose to make their voice heard—and in our case share Serena’s story – during the Big Game. Check it out: https://lnkd.in/ee-Uzuvj